Indicators

Markets:

News

Latest News about Alzheimer's disease

Recent news which mentions Alzheimer's disease

< Previous 1 2 3 4 Next >

Biogen Stock Gains Despite Extended FDA Review For Alzheimer's Therapy

May 08, 2026

The Health of the Healthcare System

August 13, 2025

Midsummer Shorties from Doc Gumshoe

July 17, 2025

This one daily habit can boost brain health and help lower risk of dementia—it's 'very overlooked,' longevity doctor says

June 17, 2025

Alzheimer’s Update and Late Winter Miscellany

March 17, 2025

'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 Update

November 25, 2024

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says

October 24, 2024

Cannabis-Based Dronabinol Could Transform Alzheimer's Care, New Study Finds

October 06, 2024

Shark Tank's Barbara Corcoran Reveals Her Struggle With Alzheimer's In Her Family

September 28, 2024

Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment

September 08, 2024

Midsummer News Flashes – Good and Not So Good

August 14, 2024

Alzheimer’s and Parkinson’s Tests and Treatments… plus a Quick COVID-19 (and Long COVID) Update

July 25, 2024

This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases

July 09, 2024

Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment

July 03, 2024

CNBC Daily Open: Tesla soars, S&P closes above 5,500

July 03, 2024

CNBC Daily Open: Tesla soars, S&P closes above 5,500

July 02, 2024

EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says

June 21, 2024

Op-ed: An Alzheimer’s wave is coming. Here's how to protect your family and your finances

February 09, 2024

Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines

January 31, 2024

Could CBD Revolutionize Alzheimer's Treatment? New Study Explores Its Neuroprotective Properties

December 04, 2023

Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others

November 21, 2023

The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks

September 30, 2023

Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning

August 24, 2023

Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain

August 03, 2023

THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities

August 02, 2023

Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment

July 20, 2023

Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year

July 17, 2023

Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know

July 08, 2023

Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024

July 07, 2023

FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline

July 07, 2023

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.